
### [NCIT:C3771](http://purl.obolibrary.org/obo/NCIT_C3771)
**Label:** Lobular Breast Carcinoma

**Subclasses:** [NCIT:C4018](http://purl.obolibrary.org/obo/NCIT_C4018) (Lobular Breast Carcinoma In Situ), [NCIT:C97049](http://purl.obolibrary.org/obo/NCIT_C97049) (Invasive Lobular Breast Carcinoma, Alveolar Variant), [NCIT:C54691](http://purl.obolibrary.org/obo/NCIT_C54691) (Invasive Lobular Breast Carcinoma, Signet Ring Variant), [NCIT:C76328](http://purl.obolibrary.org/obo/NCIT_C76328) (Metastatic Lobular Breast Carcinoma), [NCIT:C7950](http://purl.obolibrary.org/obo/NCIT_C7950) (Invasive Lobular Breast Carcinoma), [NCIT:C97051](http://purl.obolibrary.org/obo/NCIT_C97051) (Invasive Lobular Breast Carcinoma, Pleomorphic Variant), [NCIT:C137839](http://purl.obolibrary.org/obo/NCIT_C137839) (Pleomorphic Lobular Breast Carcinoma In Situ), [NCIT:C97052](http://purl.obolibrary.org/obo/NCIT_C97052) (Invasive Lobular Breast Carcinoma, Solid Variant), [NCIT:C97053](http://purl.obolibrary.org/obo/NCIT_C97053) (Invasive Lobular Breast Carcinoma, Tubulolobular Variant), 

**Class expressions from DL-Learner:**

- [NCIT:C36879](http://purl.obolibrary.org/obo/NCIT_C36879) (Lobular Carcinoma Cell) 55.56%
- [NCIT:C36878](http://purl.obolibrary.org/obo/NCIT_C36878) (Neoplastic Lobular Epithelial Cell) 55.56%
- [NCIT:C36877](http://purl.obolibrary.org/obo/NCIT_C36877) (Neoplastic Ductal Epithelial Cell) 55.56%
- [NCIT:C36858](http://purl.obolibrary.org/obo/NCIT_C36858) (Ductal Carcinoma Cell) 55.56%
- [NCIT:C36654](http://purl.obolibrary.org/obo/NCIT_C36654) (CDH1 Gene Inactivation) 55.56%
- [NCIT:C36644](http://purl.obolibrary.org/obo/NCIT_C36644) (Loss of E-cadherin Expression) 55.56%
- [NCIT:C33756](http://purl.obolibrary.org/obo/NCIT_C33756) (Terminal Ductal Lobular Unit Cell) 55.56%
- Thing 53.05%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39264](http://purl.obolibrary.org/obo/NCIT_C39264) (Angiogenesis Pathway))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39258](http://purl.obolibrary.org/obo/NCIT_C39258) (TPO Signaling Pathway))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39253](http://purl.obolibrary.org/obo/NCIT_C39253) (Interferon Signaling Modulation Pathway))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39250](http://purl.obolibrary.org/obo/NCIT_C39250) (Mucosal Healing Pathway))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39247](http://purl.obolibrary.org/obo/NCIT_C39247) (Telomere Pathway))) 40.91%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39246](http://purl.obolibrary.org/obo/NCIT_C39246) (T Cell Receptor Signaling Pathway BioCarta))) 40.91%


